Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 19 shown

Commercialized according to BDPM

BRAFTOVI 50 mg, hard capsule

Active ingredients: Encorafenib

Original BDPM details in French

Official name: BRAFTOVI 50 mg, gélule
Active ingredients: ENCORAFÉNIB
Package description: 7 plaquette(s) polyamide aluminium PVC de 4 gélule(s)

CIS 68671625CIP7 3015684CIP13 3400930156841

View details

Estimated price€1,163.74No current ANSM shortage notice is included

Commercialized according to BDPM

BRAFTOVI 75 mg, hard capsule

Active ingredients: Encorafenib

Original BDPM details in French

Official name: BRAFTOVI 75 mg, gélule
Active ingredients: ENCORAFÉNIB
Package description: 7 plaquette(s) polyamide aluminium PVC de 6 gélule(s)

CIS 60866559CIP7 3015685CIP13 3400930156858

View details

Estimated price€2,772.54No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB EG 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB EG 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 112 plaquettes prédécoupées unitaires aluminium PVC polyéthylène PVDC de 1 comprimé(s)

CIS 64990579CIP7 3020993CIP13 3400930209936

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

NEXAVAR 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: NEXAVAR 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 4 plaquette(s) polypropylène aluminium de 28 comprimé(s)

CIS 64463662CIP7 3761372CIP13 3400937613729

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

OJEMDA 100 mg, film-coated tablet

Active ingredients: TOVORAFÉNIB

Original BDPM details in French

Official name: OJEMDA 100 mg, comprimé pelliculé
Active ingredients: TOVORAFÉNIB
Package description: plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 16 comprimé(s)

CIS 63391676CIP7 3033748CIP13 3400930337486

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

OJEMDA 100 mg, film-coated tablet

Active ingredients: TOVORAFÉNIB

Original BDPM details in French

Official name: OJEMDA 100 mg, comprimé pelliculé
Active ingredients: TOVORAFÉNIB
Package description: plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 20 comprimé(s)

CIS 63391676CIP7 3033749CIP13 3400930337493

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

OJEMDA 100 mg, film-coated tablet

Active ingredients: TOVORAFÉNIB

Original BDPM details in French

Official name: OJEMDA 100 mg, comprimé pelliculé
Active ingredients: TOVORAFÉNIB
Package description: plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 24 comprimé(s)

CIS 63391676CIP7 3033752CIP13 3400930337523

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

OJEMDA 25 mg/ml, powder for oral suspension

Active ingredients: TOVORAFÉNIB

Original BDPM details in French

Official name: OJEMDA 25 mg/mL, poudre pour suspension buvable
Active ingredients: TOVORAFÉNIB
Package description: 1 flacon(s) en verre de 30 ml + 1 adaptateur pour flacon + 1 seringue pour administration orale

CIS 64661975CIP7 3033754CIP13 3400930337547

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB ACCORD 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB ACCORD 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 112 plaquettes aluminium de 1 comprimé (dose unitaire)

CIS 61654274CIP7 3026312CIP13 3400930263129

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB BIOGARAN 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB BIOGARAN 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: plaquette(s) aluminium PVC polyéthylène PVDC de 112 comprimé(s)

CIS 65332737CIP7 3022286CIP13 3400930222867

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB SANDOZ 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB SANDOZ 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 112 plaquettes prédécoupées unitaires aluminium PVC polyéthylène PVDC de 1 comprimé(s)

CIS 60687652CIP7 3020945CIP13 3400930209455

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB TEVA 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB TEVA 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 112 plaquette(s) prédécoupées unitaires PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 1 comprimé(s)

CIS 64937199CIP7 3021958CIP13 3400930219584

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB VIATRIS 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB VIATRIS 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: plaquette(s) aluminium PVC polyéthylène PVDC de 112 comprimé(s)

CIS 61442353CIP7 3021205CIP13 3400930212059

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

SORAFENIB ZENTIVA 200 mg, film-coated tablet

Active ingredients: Sorafenib, Sorafenib tosylate

Original BDPM details in French

Official name: SORAFENIB ZENTIVA 200 mg, comprimé pelliculé
Active ingredients: SORAFÉNIB, TOSILATE DE SORAFÉNIB
Package description: 112 plaquettes prédécoupées unitaires aluminium PVC polyéthylène PVDC de 1 comprimé

CIS 64232755CIP7 3021035CIP13 3400930210352

View details

Estimated price€2,479.90No current ANSM shortage notice is included

Commercialized according to BDPM

STIVARGA 40 mg, film-coated tablet

Active ingredients: Regorafenib, Regorafenib monohydrate

Original BDPM details in French

Official name: STIVARGA 40 mg, comprimé pelliculé
Active ingredients: RÉGORAFÉNIB, RÉGORAFÉNIB MONOHYDRATÉ
Package description: 3 flacon(s) polyéthylène haute densité (PEHD) de 28 comprimé(s)

CIS 69548508CIP7 2752000CIP13 3400927520006

View details

Estimated price€4,310.96No current ANSM shortage notice is included

Commercialized according to BDPM

FINLEE 10 mg, dispersible tablet

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: FINLEE 10 mg, comprimé dispersible
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 210 comprimé(s) avec 2 gobelet(s) doseur(s)

CIS 61606482CIP7 3028119CIP13 3400930281192

View details

Estimated price€3,606.10No current ANSM shortage notice is included

Commercialized according to BDPM

TAFINLAR 50 mg, hard capsule

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: TAFINLAR 50 mg, gélule
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: flacon(s) polyéthylène haute densité (PEHD) de 120 gélule(s)

CIS 61477322CIP7 2754967CIP13 3400927549670

View details

Estimated price€6,011.52No current ANSM shortage notice is included

Commercialized according to BDPM

TAFINLAR 75 mg, hard capsule

Active ingredients: DABRAFÉNIB, Dabrafenib mesylate

Original BDPM details in French

Official name: TAFINLAR 75 mg, gélule
Active ingredients: DABRAFÉNIB, MÉSILATE DE DABRAFÉNIB
Package description: flacon(s) polyéthylène haute densité (PEHD) de 120 gélule(s)

CIS 60248840CIP7 2754973CIP13 3400927549731

View details

Estimated price€8,883.40No current ANSM shortage notice is included

Commercialized according to BDPMANSM notice

ZELBORAF 240 mg, film-coated tablet

Active ingredients: VÉMURAFÉNIB

Original BDPM details in French

Official name: ZELBORAF 240 mg, comprimé pelliculé
Active ingredients: VÉMURAFÉNIB
Package description: 56 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s)

CIS 66271123CIP7 2208756CIP13 3400922087566

View details

Estimated price€2,582.92Supply disruption

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.